115 related articles for article (PubMed ID: 23969160)
1. Controlled polymorphic transformation of continuously crystallized solid lipid nanoparticles in a microstructured device: a feasibility study.
Schoenitz M; Joseph S; Nitz A; Bunjes H; Scholl S
Eur J Pharm Biopharm; 2014 Apr; 86(3):324-31. PubMed ID: 23969160
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
3. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
4. Influence of emulsifiers on the crystallization of solid lipid nanoparticles.
Bunjes H; Koch MH; Westesen K
J Pharm Sci; 2003 Jul; 92(7):1509-20. PubMed ID: 12820155
[TBL] [Abstract][Full Text] [Related]
5. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
[TBL] [Abstract][Full Text] [Related]
7. Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.
Rosenblatt KM; Bunjes H
Mol Pharm; 2009; 6(1):105-20. PubMed ID: 19049318
[TBL] [Abstract][Full Text] [Related]
8. Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles.
Bunjes H; Koch MH
J Control Release; 2005 Oct; 107(2):229-43. PubMed ID: 16023752
[TBL] [Abstract][Full Text] [Related]
9. Impact of surfactant properties on oxidative stability of beta-carotene encapsulated within solid lipid nanoparticles.
Helgason T; Awad TS; Kristbergsson K; Decker EA; McClements DJ; Weiss J
J Agric Food Chem; 2009 Sep; 57(17):8033-40. PubMed ID: 19691283
[TBL] [Abstract][Full Text] [Related]
10. Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique.
Severino P; Santana MH; Souto EB
Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1375-9. PubMed ID: 24364934
[TBL] [Abstract][Full Text] [Related]
11. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).
Helgason T; Awad TS; Kristbergsson K; McClements DJ; Weiss J
J Colloid Interface Sci; 2009 Jun; 334(1):75-81. PubMed ID: 19380149
[TBL] [Abstract][Full Text] [Related]
12. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
13. Preparation of drug nanocrystals by controlled crystallization: application of a 3-way nozzle to prevent premature crystallization for large scale production.
de Waard H; Grasmeijer N; Hinrichs WL; Eissens AC; Pfaffenbach PP; Frijlink HW
Eur J Pharm Sci; 2009 Oct; 38(3):224-9. PubMed ID: 19631270
[TBL] [Abstract][Full Text] [Related]
14. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
Garg A; Singh S
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
[TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
Mukherjee S; Ray S; Thakur RS
Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
[TBL] [Abstract][Full Text] [Related]
16. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.
Chattopadhyay P; Shekunov BY; Yim D; Cipolla D; Boyd B; Farr S
Adv Drug Deliv Rev; 2007 Jul; 59(6):444-53. PubMed ID: 17582648
[TBL] [Abstract][Full Text] [Related]
17. Formation of solid shell nanoparticles with liquid ω-3 fatty acid core.
Salminen H; Helgason T; Kristinsson B; Kristbergsson K; Weiss J
Food Chem; 2013 Dec; 141(3):2934-43. PubMed ID: 23871043
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations.
Souto EB; Wissing SA; Barbosa CM; Müller RH
Eur J Pharm Biopharm; 2004 Jul; 58(1):83-90. PubMed ID: 15207541
[TBL] [Abstract][Full Text] [Related]
19. Physical-Chemical Characterization and Formulation Considerations for Solid Lipid Nanoparticles.
Chauhan H; Mohapatra S; Munt DJ; Chandratre S; Dash A
AAPS PharmSciTech; 2016 Jun; 17(3):640-51. PubMed ID: 26292931
[TBL] [Abstract][Full Text] [Related]
20. Stability of the Metastable α-Polymorph in Solid Triglyceride Drug-Carrier Nanoparticles.
Joseph S; Rappolt M; Schoenitz M; Huzhalska V; Augustin W; Scholl S; Bunjes H
Langmuir; 2015 Jun; 31(24):6663-74. PubMed ID: 26030714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
